ArticleMolecular neurobiology2026
Brain Tissue-Derived Exosomal Proteomics Identifies Chemotaxis-Associated Protein Changes After Traumatic Brain Injury: An Exploratory Hippocampal Transcriptomic Comparison.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury (TBI) involves both primary and secondary pathological processes, including hemorrhage, ischemia, edema, and neuroinflammation. Although tissue-derived exosomes have emerged as important mediators of intercellular communication within local tissue microenvironments, their role in TBI-associated inflammatory responses remains incompletely understood. This study integrated brain tissue-derived exosomal proteomics with publicly available hippocampal transcriptomic data to investigate the potential association between tissue-derived exosomes and chemotaxis-related inflammatory responses after TBI. Brain tissue-derived exosomes were isolated, characterized, and subjected to label-free proteomic analysis. Public hippocampal transcriptomic data from GSE173975 were analyzed, and differentially expressed proteins (DEPs) and genes (DEGs) were identified from the exosomal proteomic and transcriptomic datasets, respectively. Functional enrichment, co-enrichment, and protein-protein interaction network analyses were performed, followed by quantitative real-time PCR, exosomal western blotting, and Transwell migration assays for validation and functional assessment. In total, 190 DEPs and 465 DEGs were identified. Co-enrichment analyses highlighted immune- and inflammation-related processes, particularly chemotaxis-related processes and chemokine signaling. LGALS3 and ITGB2 were increased at the exosomal protein level in brain tissue-derived exosomes from TBI rats and also showed increased hippocampal mRNA expression, whereas CCL2, CCL3, and CCR5 were upregulated at the hippocampal mRNA level. Functionally, TBI-derived exosomes enhanced BV2 microglial migration in vitro. Overall, these findings suggest that injury-associated brain tissue-derived exosomes may be associated with chemotaxis-related inflammatory and pro-migratory responses after TBI.
Indexed as
Identifiers
42572060What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.